Statement: ACI novel foods applications validated by FSA
The Association for the Cannabinoid Industry’s (ACI) novel foods applications (RP126 and RP127) have been validated by the Food Standards Agency (FSA). The ACI has received formal notification from the FSA that both its applications for the authorisation of CBD isolate and distillate ‘fall within the scope of the novel foods regime’ as set out […]
CBD Regulation: What The World Can Learn From The UK
When: Monday January 30, 20234:00pm GMT (London) | 11:00am EST (New York) | 9:00am MST (Denver) | 8:00am PST (Los Angeles) Where: Online Request access to the recording of this event The UK leads the world in the regulation of Cannabidiol (CBD) as a food and dietary supplement. In February 2020 the UK’s Food Standards […]
ACI submits complete toxicological package to the Food Standards Agency (FSA)
We are thrilled to announce that on Friday 4th November 2022, the Association for the Cannabinoid Industry submitted our complete toxicological package to the Food Standards Agency (FSA) to support the Novel Food Applications of our members. Their applications account for 33% of the public list and we look forward to them achieving validation, and […]
Farmabios
Curaleaf
Prof Christopher Hodges appointed to Chair Government’s Regulatory Horizons Council
Prof Christopher Hodges, who recently completed a strategic review of the UK legal cannabinoid industry for the CMC/ACI, has today been appointed Chair of the Regulatory Horizons Council by the Business Secretary. Steve Moore, the CMC/ACI co-founder who commissioned Hodges to lead our review has welcomed this news as a huge opportunity for the sector […]
FSA CBD List Update Statement
This morning the FSA updated their CBD list. In an associated statement Paul Tossell the FSA’s Team Leader, Novel Foods said “The list has grown to nearly 12k and is now regarded as closed. Further additions will only be by exception and judged on a case-by-case basis. Local authorities have been updated on the status […]
